{
    "2018-08-20": [
        [
            {
                "time": "2018-03-15",
                "original_text": "LCI Whacked On Contract Loss, CWBR Awaits Data, Busy Months Ahead For PLSE",
                "features": {
                    "keywords": [
                        "LCI",
                        "Contract Loss",
                        "CWBR",
                        "PLSE"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Regeneron's Eylea Gets FDA Nod for Wet AMD as a 12-Week Dose",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Eylea",
                        "FDA",
                        "Wet AMD"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-07",
                "original_text": "Amgen Stock Up This Year So Far: Will the Rally Continue?",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Stock Up",
                        "Rally"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-18",
                "original_text": "Regeneron's Eylea Gets FDA Nod for Wet AMD as a 12-Week Dose",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Eylea",
                        "FDA",
                        "Wet AMD"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-22",
                "original_text": "Novan Rallies On Positive Early Results For Inflammatory Skin Disease Medication",
                "features": {
                    "keywords": [
                        "Novan",
                        "Positive Results",
                        "Skin Disease"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-10",
                "original_text": "Mylan Cuts Its Fiscal 2018 Guidance, Citing US Market Challenges",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Fiscal Guidance",
                        "US Market Challenges"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "Mylan Has a Strong Balance Sheet despite Weak Q2 Performance",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Balance Sheet",
                        "Q2 Performance"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-20",
                "original_text": "The Swiss Stock Market Rose On Hopes For Trade Agreement",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Trade Agreement"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-25",
                "original_text": "Novan Announces Promising Clinical Results with SB414",
                "features": {
                    "keywords": [
                        "Novan",
                        "Clinical Results",
                        "SB414"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}